Will Cannabis Seeds

Will Cannabis Genetics Be Restricted?

A redefinition of hemp under national law, set to take effect Nov. 12, spells the end of Farm Bill safeguards for many hemp-derived THC products across the nation: low-dose beverages as well as THCA flower and delta-8 THC gummies, vapes and additional products available at gas stops and smoke shops.

But the hemp prohibition also generates a major complication for the legitimate cannabis industry. Seeds from cannabis varieties that generate flower with greater than 0.3% THC are no longer legal to ship out of state.

Although seed purchases will likely continue in authorized states, the changes threaten to shutter some seed suppliers and genetics businesses, observers say, while creating supply-chain issues for cannabis growers and retailers.

"If this language goes through, we will need pop-up stores to sell seeds in every state where it's permitted," Campanella said. "Which is why we're also offering clones and tissue cultivation, because that's not included in the bill."

When are cannabis genetics and clones prohibited to ship across state lines?

The updated regulations classify seeds depending on the THC potential of the mother plant. Genetic substances such as seeds and clones are rendered illegal if the final product exceeds the threshold.

For now, seeds are currently shipping under the 2018 Farm Bill's current quo. But the clock is ticking for businesses like Brothers Grimm and for cannabis cultivators who worry about supply chain disruptions if out-of-state availability to genetics is prohibited.

Most of the cannabis industry remains mostly unaware of the impending shutdown of the interstate genetics market, said Ryan Power, co-founder of Sebastopol, California-based company Atlas Seed.

Without government intervention in the form of an exception for seeds or a general moratorium, many seed suppliers will just be shuttered come November, he added.

"We are functioning legally currently, but if that changes, it will disrupt the legal licensed sector in each state," said Power, whose customers includes seed banks as well as licensed commercial cultivators.

"Consumers are going to forfeit choice, and it will be a significant shutdown for most people."

What are cannabis seed suppliers doing to remain legal after the federal hemp ban?

Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which tightened cannabis supervision in that state while also limiting hemp-derived THC products to licensed cannabis retailers.

Previously a seed supplier, Silberhaze is currently focused on the marketing, preservation and IP safeguarding of premium plant genetics.

That's because seed companies hoping to stay compliant in this updated environment must have airtight documentation, https://nativesusa.com/ (https://nativesusa.com) he said.

"You have to prove where this stuff comes from, so it's extremely important to have documentation, even to the extent where you have cultivator names," Silber said.

"Smaller businesses will have to operate with better records and a better chain of possession," he added. "We want that documentation ourselves, because we don't want to be working with shady sources."

To prevent seizures and other legal fallout, seed entrepreneurs must "get their affairs in order" before the updated regulations take effect, Silber said.

"Review all your materials immediately, and categorize what you can," Silber said. "Take stock, document your heritage, preserve breeder records, and organize any cannabinoid or terpene data you currently have. If regulations shift, you'll be in a much better position to understand what may be affected and make informed decisions."

Does government marijuana rescheduling affect cannabis genetics?

Silber believes U.S. Drug Enforcement Administration registration may be necessary for businesses engaged in research.

But for the time being, seed companies can't register with the DEA like state-licensed medical cannabis operators can. Such a pathway is unavailable to seed suppliers, nurseries or genetics businesses, said Jim Ickes, an attorney and partner with Frantz Ward's cannabis practice group in Cleveland.

"Seed-related activity may be occurring inside larger state-licensed therapeutic marijuana businesses, as some states permit dispensaries or registered medical operators to offer seeds, clones or personal growing materials," he said.

"But that is different from the DEA establishing a freestanding seed supplier registration category."

Some genetics companies are already changing operational practices to comply with the updated law. According to Ickes, they must address questions including:

• Which of our varieties produce plants above 0.3% total THC?
• Which seeds remain as hemp after Nov. 12, 2026, and which don't?
• What does our catalog look like once we organize it against the viable-seed exclusion?

Ickes also understands confusion from clients who believed government rescheduling of medical marijuana would resolve their situation with financial institutions. However, the latest regulatory language has shifted those conversations beyond the basics of classification, he said.

"Financial institutions ask whether this specific revenue source is legal, whether it ties to state-licensed operations, or whether there's cross-state risk," said Ickes.

"After November, a seed supplier selling drug-type genetics can't address the first question with the hemp definition. It has to refer to a lawful state cannabis pathway instead. Seed banks dealing in authentic industrial-hemp seed maintain the cleaner story."

What's the future of cannabis genetics?

Campanella is part of a new coalition of other breeders, growers and researchers that's arguing seeds are more appropriately defined as farm inputs than controlled substances. To that end, seeds should be managed by the U.S. Department of Agriculture, leaving the DEA to focus its enforcement work elsewhere.

"How do you control something based on what it could become one day?" said Campanella. "Our preference is to have that wording removed, or have seeds regulated by the USDA as a hemp product."

But in the meantime, Campanella is restructuring Brothers Grimm to function outside the reach of shifting federal oversight. The business plans to maintain its Colorado seed facility while placing its Oklahoma tissue culture facility as a safeguard against federal prohibition of cannabis seeds.

As she explained: "If things evolve in a way where we can't focus on interstate shipping, we'll have additional resources to satisfy people's requirements without putting ourselves in trouble."